Virax Biolabs Group Ltd.
viraxbiolabs.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Virax Biolabs Group Ltd.
Financing Quarterly Statistics, Q4 2022
During Q4, biopharmas brought in an aggregate $17.5bn in financing and device company fundraising totaled $1.9bn; while in vitro diagnostic firms and research tools players raised $848m.
Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances
The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and experts reveal what they are most excited about on the technology front.
Financing Quarterly Statistics, Q3 2022
During Q3, biopharmas brought in an aggregate $18.1bn in financing and device company fundraising totaled $5.1bn; while in vitro diagnostic firms and research tools players raised $771m.
Company Information
- Industry
- Biotechnology
- Laboratory Testing Services
- Services
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
Medical Devices
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice